OTC
0.12USD
+0.01 (+13.64%)
We have scored 3 news catalysts on Avai Bio, Inc. (AVAI) over the past 12 months. The biggest single-day move next to one of them came Dec 9, 2025, when AVAI closed +4.8%: “Avant Technologies and Austrianova Advancing α-Klotho Cell Therapy as Mayo Clinic Study Links Low α-Klotho Levels to Poor Cardiovascular Survival”. Coverage across the window leans positive (average ticker sentiment +0.60). Most of the impact sits in sector healthcare and interest rate sensitivity duration.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
15.9M
P/E
—
EPS
—
Beta
0.87
52W range
0.101-0.8
Day range
0.10–0.12
Open
0.10
Prev close
0.10
Volume
156.6K
Avg volume
143.4K
Dividend
0.00
IPO
2020-04-06
Avai Bio, Inc. operates as a holding company primarily focused on creating websites and mobile applications that offer users personalized and convenient experiences. Its business activities include providing IT consulting services and making artificial intelligence accessible to the general public. The company was established on November 6, 2017, and its main office is situated in Las Vegas, Nevada.
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about Avai Bio, Inc. — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for AVAI: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
